Business Wire

Hypernative Raises $40M Series B to Remove Security Barriers to Web3 Mass Adoption

10.6.2025 15:30:00 EEST | Business Wire | Press release

Share

Hypernative, the leading provider of real-time threat prevention in Web3, today announced a $40 million Series B funding round co-led by Ten Eleven Ventures and Ballistic Ventures, with participation from StepStone Group, and existing investors boldstart ventures and IBI Tech Fund.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610162307/en/

Hypernative team

The funds will support the expansion of the company’s offering to include fraud prevention and wallet-level transaction protection—key steps toward building an end-to-end security platform for Web3. They will also fuel improvements to AI models through wider investment into high-quality training data, and support team growth to provide expert-driven risk analysis and customer support.

In 2024, Hypernative detected over $2.2 billion of losses from hacks, exploits, phishing, and fraud—a 22% jump from the previous year. Following the $1.4 billion Bybit hack in February, the industry is on track for another record-breaking year of security failures.

Hypernative uses AI-powered detection to respond to threats in real time, helping secure transactions and build trust across the Web3 ecosystem. The platform, used by over 200 customers to help protect more than $100 billion in assets, continues to evolve through ongoing integrations. With recent expansion into wallets, exchanges, and payment providers, Hypernative is contributing to a more unified approach to Web3 security.

Gal Sagie, Co-founder and CEO of Hypernative, said: “Web3 is at an inflection point: clear regulation is finally emerging, and institutional adoption is accelerating led by stablecoins and tokenized assets. But security remains the biggest blocker to mass adoption—and Hypernative is on a mission to close that gap.”

The funding round follows a number of exciting milestones for the company:

  • Over the past year, Hypernative has more than doubled its network coverage to 60+ chains, including Solana and THORChain, enhancing security with hundreds of detectors to identify the industry's largest set of risks across not just security, but also financial, compliance and governance.
  • The launch of Guardian, a real-time transaction security solution that protects against blind signing by simulating the outcome of every transaction before it is approved.
  • Additionally, the team launched new ways of integrating Hypernative threat intelligence directly into a project's contracts or prior to block inclusion with sequencer integrations, frontend apps, liquidity pools, staking, and more.

“As leading cybersecurity investors, Ten Eleven recognizes how critical a robust security layer is to furthering adoption of Web3 technologies. Hypernative’s cohesive approach to real-time threat detection and response positions it as a foundational player in the future of decentralized ecosystems. That’s why we are proud to lead the Series B round and look forward to supporting the company through its next stage of growth,” said Mark Hatfield, Co-founder and General Partner of Ten Eleven Ventures.

"Hypernative is tackling the single greatest barrier to Web3’s mainstream future: trust. As attacks grow more sophisticated, the need for proactive, real-time security has never been more urgent," said Barmak Meftah, Co-founder and General Partner, Ballistic Ventures. "What Gal and the Hypernative team have built is not just innovative, it’s foundational to the next era of the internet. We're proud to back them as they scale their platform, expand their AI capabilities, and secure the path to mass adoption."

Hypernative's customer base ranges from chains, wallets, and protocols to exchanges, asset managers, and stablecoin issuers. More than 200 Web3 projects already rely on Hypernative for their security, with Aptos, Ethereum, Morpho, Movement, Sonic, Star Atlas, Wintermute, and ZKsync joining the list earlier this year.

To learn more about how Hypernative stops Web3 threats before they do any damage, visit: https://hypernative.io

About Hypernative

Hypernative is a real-time monitoring, risk detection and automated response solution that identifies threats with high accuracy and gives customers precious minutes to respond before exploits can do damage. The platform tracks both onchain and offchain data sources and uses battle-tested, sophisticated machine learning models, heuristics, simulations, and graph-based detections to identify over 300 risk types, from smart contract hacks and bridge security incidents to frontend compromises, market manipulations and private key theft. For more information, visit hypernative.io.

About Ten Eleven Ventures

Ten Eleven Ventures is the original cybersecurity-focused, global and stage-agnostic investment firm. The firm finds, invests in and helps grow top cybersecurity companies addressing critical digital security needs, tapping its team, network and experience to help build successful businesses. Since its founding, Ten Eleven Ventures has raised over $US1 billion and made over 60 cybersecurity investments across stages worldwide, including KnowBe4, Darktrace, Axis Security, Twistlock, Verodin, Cylance and Ping Identity. For more information, please visit 1011vc.com.

About Ballistic Ventures

Ballistic Ventures is a venture capital firm solely dedicated to early-stage cybersecurity and cyber-related companies. The partners have spent their entire careers defending against every cyber threat conceivable. Members of the firm have founded, operated, and funded over 100 successful cybersecurity firms – including Abnormal Security, AlienVault, ArcSight, Fortify, Mandiant, and Shape Security – led over 10,000 security professionals globally, and have 40+ years of experience in venture capital. Our experience provides entrepreneurs impactful support from people focused on the same mission. Our networks and relationships open doors for our founders. Learn more at ballisticventures.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250610162307/en/

Contacts

Hypernative Press Contact:
Oliver Senchal
oliver@hypernative.io

Ten Eleven Ventures Press Contact:
Monsy Carlo
monsy@1011vc.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Leaders of Dubai-Based Unicorns Hail City as Global Innovation Hub Shaping Future Technology and Driving the Digital Economy20.4.2026 16:08:00 EEST | Press release

Leaders of Dubai-based unicorn companies have reaffirmed the emirate’s status as a global hub for digital innovation and technology-led growth. The senior executives highlighted Dubai’s forward-looking regulatory environment, advanced infrastructure, and ability to attract international talent as key factors strengthening its appeal for high-growth digital businesses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420503062/en/ Leaders of Dubai-based unicorns hail city as global innovation hub shaping future technology and driving the digital economy (Photo: AETOSWire) They noted that Dubai has evolved into a strategic launchpad for ambitious companies, offering an agile business environment that supports innovation and enables expansion into regional and international markets. The business leaders also praised the strong alignment between the public and private sectors within Dubai’s digital ecosystem, supported by Dubai

Capcom’s All-New IP PRAGMATA Surpasses One Million Units Sold in Two Days!20.4.2026 16:00:00 EEST | Press release

Capcom Co., Ltd. (TOKYO:9697) today announced that worldwide sales of PRAGMATA, the company’s all-new IP released on April 17, 2026*, have surpassed one million units. PRAGMATA is a science-fiction action-adventure game that depicts the journey of Hugh Williams and Diana, an android girl, in a near-future lunar world. A completely new IP, PRAGMATA was developed primarily by a team of younger Capcom developers, who created an innovative gameplay experience by fusing action gameplay with puzzle elements set within a distinctive world ruled over by artificial intelligence. In the absence of an established fan base or preexisting brand recognition, Capcom implemented a range of marketing initiatives—beginning with the early release of a playable demo—to communicate the unique features of the game to a wider audience. In addition, in line with the company’s multi-platform strategy, Capcom broadened the title’s availability by adding support for Nintendo Switch™ 2 at an early stage. As a res

Capcom’s All-New IP PRAGMATA Surpasses One Million Units Sold in Two Days!20.4.2026 16:00:00 EEST | Press release

Capcom Co., Ltd. (TOKYO:9697) today announced that worldwide sales of PRAGMATA, the company’s all-new IP released on April 17, 2026*, have surpassed one million units. PRAGMATA is a science-fiction action-adventure game that depicts the journey of Hugh Williams and Diana, an android girl, in a near-future lunar world. A completely new IP, PRAGMATA was developed primarily by a team of younger Capcom developers, who created an innovative gameplay experience by fusing action gameplay with puzzle elements set within a distinctive world ruled over by artificial intelligence. In the absence of an established fan base or preexisting brand recognition, Capcom implemented a range of marketing initiatives—beginning with the early release of a playable demo—to communicate the unique features of the game to a wider audience. In addition, in line with the company’s multi-platform strategy, Capcom broadened the title’s availability by adding support for Nintendo Switch™ 2 at an early stage. As a res

Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer20.4.2026 15:30:00 EEST | Press release

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of its PKMYT1 inhibitor, lunresertib (Debio2513), and its WEE1 inhibitor, zedoresertib (Debio 0123). The designation is for the treatment of adult patients with CCNE1 amplified, or a deleterious mutation in either FBXW7 or PPP2R1A, platinum-resistant/refractory ovarian cancer. The FDA’s Fast Track program is designed to facilitate the development and expedite the review of new drugs intended to treat serious conditions and fill an unmet medical need. Programs granted Fast Track designation benefit from more frequent communication with the FDA and, if relevant criteria are met, may be eligible for Priority Review and Accelerated Approval of a New Drug Application (NDA). Momentum Following AACR O

Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer20.4.2026 15:30:00 EEST | Press release

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of its PKMYT1 inhibitor, lunresertib (Debio2513), and its WEE1 inhibitor, zedoresertib (Debio 0123). The designation is for the treatment of adult patients with CCNE1 amplified, or a deleterious mutation in either FBXW7 or PPP2R1A, platinum-resistant/refractory ovarian cancer. The FDA’s Fast Track program is designed to facilitate the development and expedite the review of new drugs intended to treat serious conditions and fill an unmet medical need. Programs granted Fast Track designation benefit from more frequent communication with the FDA and, if relevant criteria are met, may be eligible for Priority Review and Accelerated Approval of a New Drug Application (NDA). Momentum Following AACR O

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye